Rafel El-Atassi, MD
Cardiology · Elyria, OHNPI 1588623508
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $17,281 of the $23,351 with a category attached, or 74.0%. 21 manufacturers reported payments, led by Medtronic at 51.7% of the total. Reporting peaked in 2024 at $9,844 and has fallen 52.9% since, to $4,632 in 2025. Among cardiology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 180 payments — averaging $129.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$12K
- Boston Scientific$7K
- Medical Device Business Services, Inc.$2K
- Abbott$2K
- Atricure, Inc.$264
- Impulse Dynamics (USA) Inc.$200
- plus $435 from 15 others
What the payments were for
- Consulting fees$220%
- Travel & lodging$17,28174%
- Food & beverage$5,97826%
- Education$700%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 83 | $12,064 |
| Boston Scientific | 30 | $6,532 |
| Medical Device Business Services, Inc. | 25 | $2,347 |
| Abbott | 10 | $1,508 |
| Atricure, Inc. | 5 | $264 |
| Impulse Dynamics (USA) Inc. | 4 | $200 |
| Johnson & Johnson | 4 | $66 |
| Edwards Lifesciences | 1 | $58 |
| Merck | 3 | $47 |
| Philips North America LLC | 2 | $40 |
| Actelion Pharmaceuticals US, Inc. | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Z-medica, LLC | 1 | $22 |
| Pfizer | 1 | $22 |
| Bayer | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $15 |
| Amgen | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Farapulse$2,987
- Arctic Front$2,594
- Carto 3$1,845
- RHYTHMIA$1,309
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- ENSITE$747
- Micra$538
- NA$508
- ARCTIC FRONT ADVANCE$275
- OPTIMIZER$245
- AZURE XT DR MRI SURESCAN$134
How this compares
$23,351 in reported general payments places this provider in the 95th percentile of 30 cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 43 | $41,161 |
| EliquisApixaban | 30 | $33,447 |
| Dofetilide | 86 | $10,857 |
| Amiodarone Hcl | 30 | $620 |
| Flecainide Acetate | 26 | $602 |
| Metoprolol Succinate | 57 | $395 |
| Potassium Chloride | 20 | $218 |
| Spironolactone | 35 | $205 |
| Pantoprazole Sodium | 19 | $157 |
| SotalolSotalol Hcl | 11 | $152 |
| Cephalexin | 23 | $141 |
| Metoprolol Tartrate | 38 | $124 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $66 | $41,16143 claims |
| PfizerEliquis | $22 | $33,44730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 30 cardiology providers in Ohio.
Other cardiology in Elyria
- Luis Augusto Palma DallanCleveland$61K
- Haytham MouslyCleveland$17K
- Mazen MahjoubWarren$9K
- Vinay ChitkaraLondon$8K
- Farshad ForouzandehParma$6K
- Vijay RavipatiColumbus$3K
- Basel MoussaFairview Park$2K
- Robert OkyereCleveland$102
- William MarshallColumbus$0
- Scott MaffettColumbus$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.